GlassScriptPhysician profile
Michael Edwin Confer
NPI 1336346337
$1,861.93
in general payments reported to CMS, 2019-2025
39 companies · $636 in 2025
The $636 reported for 2025 was more than what 79% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $57.91 · 2022: $64.56 · 2023: $392 · 2024: $499 · 2025: $636.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,511 · Education: $15.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,510.83 |
| Education | $15.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novocure INC. | $231.72 | 2019-2023 | Optune |
| Janssen Biotech, INC. | $140.12 | 2023-2025 | Erleada, Rybrevant, Darzalex |
| Regeneron Healthcare Solutions, INC. | $123.30 | 2024-2025 | Libtayo, Lynozyfic |
| Merck Sharp & Dohme LLC | $119.61 | 2024-2025 | Keytruda, Welireg, Lynparza |
| Astrazeneca Pharmaceuticals LP | $113.04 | 2023-2025 | Lynparza, Enhertu |
| Novartis Pharmaceuticals Corporation | $88.83 | 2023-2025 | |
| Seagen INC. | $74.67 | 2020-2023 | Padcev, Adcetris |
| Lilly USA, LLC | $65.18 | 2024-2025 | Jaypirca, Verzenio, Retevmo |
| Sobi, INC | $58.47 | 2022-2025 | |
| Icotec Medical INC. | $57.90 | 2022-2023 | Icotec Blackarmor Spine System |
| Daiichi Sankyo INC. | $52.59 | 2025 | Enhertu, Injectafer |
| Ion Beam Applications S.A. | $51.00 | 2019 | |
| Sumitomo Pharma America, INC. | $48.73 | 2023 | Orgovyx |
| Eisai INC. | $47.30 | 2024 | |
| Genentech USA, INC. | $42.44 | 2024-2025 | Polivy, Lunsumio, Columvi |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Confer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.